Unique Surface Structures on Synovial Cells
Unique Surface Structures on Synovial Cells
批准号:
6876671
负责人:
David Alan Fox
金额:
$26.47万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 2007-03-31
关键词:
CD antigensT lymphocyteapoptosisbiomarkercell adhesion moleculescell cell interactioncell morphologyclinical researchcytokinedisease /disorder modelfibroblastsgene expressionhuman subjecthuman tissueleukocyte activation /transformationmicroarray technologymonoclonal antibodypatient oriented researchrheumatoid arthritissynovial membrane
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by the applicant): In rheumatoid arthritis (RA)
inflammation and ultimate destruction of articular structures are accompanied
by extensive infiltration of synovium by T lymphocytes and macrophages, and
hyperplasia of synovial fibroblasts (SF). The role of T lymphocytes remains
controversial, with no conclusive proof for T cell directed autoimmunity as the
cause of RA. We have taken several approaches to better understand pathways of
T cell activation and of the role of T cells in RA, including generation of
monoclonal antibodies to novel T cell surface antigens, and ligands of surface
structures important for T cell activation, including ligands expressed on SF.
In addition we have developed evidence that T cells, even resting T cells, can
interact with SF in a bi-directional manner. Thus SF can function as potent
accessory cells for T cell activation, while resting T cells can stimulate a
proinflammatory pattern of gene expression in SF, even in the absence of
stimuli that activate the T cell. We have termed this ability of unactivated T
lymphocytes to stimulate the SF "effector function of resting T cells." We now
propose that a significant component of the aggressive behavior of SF in RA
arises from direct interactions between T cells and RA SF. We also hypothesize
that the molecular basis for this unusual and pathogenic program of cell
differentiation arises from a unique immunologic synapse formed between the T
lymphocyte and the SF. The current proposal would further analyze the molecular
interactions between T cells and SF and the functional consequences of these
interactions, using both morphologic and immunologic approaches. A novel ligand
of CD6 expressed by SF will be molecularly characterized and functionally
studied. New antibodies will be generated to analyze the T cell/SF microarray
analysis of SF gene expression, and quantitative interaction, directed at both
known and novel cell surface molecules and at the secreted CD26-related cell
interaction molecule attractin. Activation of SF will be studied using
measurement of relevant RNA species and protein products, such as osteoclast
differentiation factor, cytokines, and tissue destructive proteases. The
proposed studies represent a fresh approach to understanding RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Michigan Clinical Autoimmunity Center of Excellence
-
批准号:10662184
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2019
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Clinical Autoimmunity Center of Excellence
-
批准号:9916706
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2019
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Clinical Autoimmunity Center of Excellence
-
批准号:10380100
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2019
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Clinical Autoimmunity Center of Excellence
-
批准号:10165485
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2019
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
-
批准号:8842928
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2014
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
-
批准号:9480038
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2014
-
负责人:David Alan Fox
-
依托单位:
Administrative Core
-
批准号:7530526
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2007
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Core Center
-
批准号:6781096
-
项目类别:
-
资助金额:$60.13万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Research Core Center
-
批准号:7938844
-
项目类别:
-
资助金额:$58.99万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
CORE--HYBRIDOMA FACILITY
-
批准号:6416838
-
项目类别:
-
资助金额:$11.52万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
CORE--HYBRIDOMA FACILITY
-
批准号:6548052
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Research Core Center
-
批准号:7270632
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Research Core Center
-
批准号:7483086
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Core Center
-
批准号:6643583
-
项目类别:
-
资助金额:$60.27万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Core Center
-
批准号:6533033
-
项目类别:
-
资助金额:$60.19万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Core Center
-
批准号:6437857
-
项目类别:
-
资助金额:$51.15万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Core Center
-
批准号:6942766
-
项目类别:
-
资助金额:$60.19万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
University of Michigan Rheumatic Diseases Research Core Center
-
批准号:7662391
-
项目类别:
-
资助金额:$59.04万
-
财政年份:2001
-
负责人:David Alan Fox
-
依托单位:
CORE--HYBRIDOMA FACILITY
-
批准号:6299782
-
项目类别:
-
资助金额:$11.52万
-
财政年份:2000
-
负责人:David Alan Fox
-
依托单位:
CORE--HYBRIDOMA FACILITY
-
批准号:6100322
-
项目类别:
-
资助金额:$10.9万
-
财政年份:1999
-
负责人:David Alan Fox
-
依托单位:
海外基金